VIVELLEDOT 37.5 micrograms/24 hours, medicated transdermal patch 8 patches in individual sachets
Active ingredients: 17β-estradiol, Estradiol hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch8 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIVELLEDOT 37,5 microgrammes/24 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 8 sachet(s) aluminium de 1 dispositif(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69953524CIP73585805CIP133400935858054Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ESTRADIOLdispositif | 0,585 mg · un dispositif transdermique de 3,75 cm² | FT |
| ESTRADIOL HÉMIHYDRATÉdispositif | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.